Abstract
Mycobacterium tuberculosis is infectious bacteria and causes tuberculosis in humans. M. tuberculosis infects the immune deficient human and shows the symptoms of the infection. Also bacteria stay in latent phase inside the human body and can be active in suitable conditions. One third of the total population of the world is infected by M. tuberculosis; therefore it is very important to have potential drugs against tuberculosis. Mycobacteria have reported multidrug resistance to the available drugs for tuberculosis. Hence, there is a need to find a new target for the drugs. Fatty acid synthase II (FAS II) is the enzyme that catalyzes the synthesis of fatty acid and is not found in humans. It is a multifunctional polypeptide, composed of different domains in which can be targeted individually to inhibit the function of FAS II. 2-Nitropropane Dioxygenase is a part of enoyl reductase domain in FAS II and can be potentially targeted. In this study, the homology modeling of 2NPD from M. tuberculosis has been done and small molecules that have the potential to bind and inhibit the function of the enzyme have been identified. Also the stability of proteinligand complex was determined.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
